Wendy T. N. Swelsen

Wendy T. N. Swelsen

Auto-generated profile, based on publicly available information

Wendy T. N. Swelsen

Department of Immunogenetics Sanquin Diagnostic Services Amsterdam The Netherlands

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JBJesse Bruijnesteijn
Jesse Bruijnesteijn
MWMarit K. H. van der Wiel
Marit K. H. van der Wiel
WSWendy T. N. Swelsen
Wendy T. N. Swelsen
NONel Otting
Nel Otting
AVAnnemiek J. M. de Vos-Rouweler
Annemiek J. M. de Vos-Rouweler
RBRonald E Bontrop
Ronald E Bontrop
The killer-cell Ig-like receptors (KIRs) play a central role in the immune recognition in infection, pregnancy, and transplantation through their interactions with MHC class I molecules. KIR genes display abundant copy number variation as well as high levels of polymorphism. As a result, it is challenging to characterize this structurally dynamic region. KIR haplotypes have been analyzed in different species using conventional characterization methods, such as Sanger sequencing and Roche/454 pyrosequencing. However, these methods are time-consuming and often failed to define complete haplotypes, or do not reach allele-level resolution. In addition, most analyses were performed on genomic DNA, and thus were lacking substantial information about transcription and its corresponding modifications. In this paper, we present a single-molecule real-time sequencing approach, using Pacific Biosciences Sequel platform to characterize the KIR transcriptomes in human and rhesus macaque (Macaca mulatta) families. This high-resolution approach allowed the identification of novel Mamu-KIR alleles, the extension of reported allele sequences, and the determination of human and macaque KIR haplotypes. In addition, multiple recombinant KIR genes were discovered, all located on contracted haplotypes, which were likely the result of chromosomal rearrangements. The relatively high number of contracted haplotypes discovered might be indicative of selection on small KIR repertoires and/or novel fusion gene products. This next-generation method provides an improved high-resolution characterization of the KIR cluster in humans and macaques, which eventually may aid in a better understanding and interpretation of KIR allele–associated diseases, as well as the immune response in transplantation and reproduction.

18 January 2024 in HLA
Verified
Journal Article
Open access
TKTineke Kardol-Hoefnagel
Tineke Kardol-Hoefnagel
DSDanial Mohammadi Senejohnny
Danial Mohammadi Senejohnny
EKElena G. Kamburova
Elena G. Kamburova
BWBram W. Wisse
Bram W. Wisse
LRLeon Reteig
Leon Reteig
HOHenny G. Otten
Henny G. Otten
In kidney transplantation, survival rates are still partly impaired due to the deleterious effects of donor specific HLA antibodies (DSA). However, not all luminex‐defined DSA appear to be clinically relevant. Further analysis of DSA recognizing polymorphic amino acid configurations, called eplets or functional epitopes, might improve the discrimination between clinically relevant vs. irrelevant HLA antibodies. To evaluate which donor epitope‐specific HLA antibodies (DESAs) are clinically important in kidney graft survival, relevant and irrelevant DESAs were discerned in a Dutch cohort of 4690 patients using Kaplan–Meier analysis and tested in a cox proportional hazard (CPH) model including nonimmunological variables. Pre‐transplant DESAs were detected in 439 patients (9.4%). The presence of certain clinically relevant DESAs was significantly associated with increased risk on graft loss in deceased donor transplantations (p < 0.0001). The antibodies recognized six epitopes of HLA Class I, 3 of HLA‐DR, and 1 of HLA‐DQ, and most antibodies were directed to HLA‐B (47%). Fifty‐three patients (69.7%) had DESA against one donor epitope (range 1–5). Long‐term graft survival rate in patients with clinically relevant DESA was 32%, rendering DESA a superior parameter to classical DSA (60%). In the CPH model, the hazard ratio (95% CI) of clinically relevant DESAs was 2.45 (1.84–3.25) in deceased donation, and 2.22 (1.25–3.95) in living donation. In conclusion, the developed model shows the deleterious effect of clinically relevant DESAs on graft outcome which outperformed traditional DSA‐based risk analysis on antigen level.

24 April 2013 in Tissue Antigens
Verified
Journal Article
Closed access
WSW. T. N. Swelsen
W. T. N. Swelsen
KHK. S. Hartog
K. S. Hartog
NLN. M. Lardy
N. M. Lardy

29 December 2023 in HLA
Verified
Journal Article
Open access
TKTineke Kardol-Hoefnagel
Tineke Kardol-Hoefnagel
DSDanial Mohammadi Senejohnny
Danial Mohammadi Senejohnny
EKElena G. Kamburova
Elena G. Kamburova
BWBram W. Wisse
Bram W. Wisse
MGMaartje L. Gruijters
Maartje L. Gruijters
HOHenny G. Otten
Henny G. Otten
In kidney transplantation, donor HLA antibodies are a risk factor for graft loss. Accessibility of donor eplets for HLA antibodies is predicted by the ElliPro score. The clinical usefulness of those scores in relation to transplant outcome is unknown. In a large Dutch kidney transplant cohort, Ellipro scores of pretransplant donor antibodies that can be assigned to known eplets (donor epitope specific HLA antibodies [DESAs]) were compared between early graft failure and long surviving deceased donor transplants. We did not observe a significant Ellipro score difference between the two cohorts, nor significant differences in graft survival between transplants with DESAs having high versus low total Ellipro scores. We conclude that Ellipro scores cannot be used to identify DESAs associated with early versus late kidney graft loss in deceased donor transplants.

21 January 2020 in HLA
Verified
Journal Article
Closed access
PDF file
WSWendy T. N. Swelsen
Wendy T. N. Swelsen
GTGayatri C. Tetar
Gayatri C. Tetar
SVSamantha V. Varlack
Samantha V. Varlack
AMAbir Matar
Abir Matar
NLNeubury M. Lardy
Neubury M. Lardy